Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company that offers AI-powered software to help providers better understand cancer risk, ...
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ -- ...
SAN DIEGO, CA, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- CureMetrix ®, a leader in AI-based solutions for mammography, announces that they have entered ...
WELLINGTON, New Zealand, Dec. 13, 2023 /PRNewswire/ -- Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX:VHT), a global leader in software for the early detection of breast ...
South Korean artificial intelligence software developer Lunit Inc. plans to acquire Volpara Health Technologies Ltd. for $193 million (AUD 292 million) by mid-2024, taking a global leap to the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results